Manganese-Based Contrast Agents as a Replacement for Gadolinium.

Area of Science:

• Medical Imaging
• Radiology
• Contrast Agents

Background:

• Gadolinium-based contrast agents (GBCAs) are widely used in medical imaging.
• Concerns regarding gadolinium retention and potential long-term effects necessitate the exploration of alternatives.
• Manganese-based contrast agents (MBCAs) have emerged as a potential alternative due to their paramagnetic properties.

Purpose of the Study:

• To systematically evaluate peer-reviewed research on manganese-based contrast agents.
• To determine if MBCAs are a safe and effective alternative to gadolinium-based contrast agents.

Main Methods:

• A systematic literature search was conducted across three academic databases.
• Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed.
• Inclusion and exclusion criteria were applied to select relevant studies.

Main Results:

• Eighteen articles met the inclusion criteria for the systematic review.
• The selected articles covered seven categories of MBCAs based on chelating molecules and structure.
• Most MBCAs met or exceeded efficacy benchmarks for T1 contrast enhancement.
• Safety data was sparse in the reviewed literature, though available information was generally promising.

Conclusions:

• MBCAs demonstrate significant potential for pathology visualization, comparable to gadolinium-based agents.
• Further research is required to thoroughly evaluate the safety of MBCAs.
• Standardized protocols for testing MBCAs are needed to facilitate direct comparisons with gadolinium agents.